CADD-Solis Ambulatory Infusion Pumps with Software Defects Affecting Device Responsiveness
CADD-Solis Model 2100 infusion pumps with pre-v4.3 software have defects affecting occlusion detection and device responsiveness. Manufacturer recommends updating to software version 4.3 (2023) to resolve the issues.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification requires minimum severity level 4. Multiple software defects affecting critical infusion pump functions including occlusion detection and device responsiveness could impact medication delivery safety, though no injuries or illnesses have been reported.
Plain-English summary
Smiths Medical ASD Inc. is notifying users of CADD-Solis Ambulatory Infusion Pumps, Model 2100, that pumps with software versions before 4.3 contain multiple defects. This recall affects approximately 9,284 units distributed worldwide.
The software defects include: upstream occlusion detection failure, unresponsive stop and power keys, manual mode air detector issues, single bubble air detection failure, error codes not displayed at power-up, audible alarm problems, low sensitivity air-in-line detection threshold, and PharmGuard Server password issues. These defects could impact the device's ability to detect occlusion and air in the line, as well as responsiveness to user commands.
The CADD-Solis pumps are indicated for intra-arterial, subcutaneous, intraperitoneal, and epidural infusions, as well as therapies requiring continuous or intermittent medication delivery. Patients and healthcare facilities using these pumps are affected.
Healthcare facilities and users should immediately update their CADD-Solis pumps to software version 4.3 (released in 2023), which contains corrections for these defects. Smiths Medical has already incorporated these corrections into all subsequent software releases beyond v4.3.
The recalled product
- Product
- CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that re
- Manufacturer
- Smiths Medical ASD Inc.
- Hazard
- occlusion-detection-failure
- unresponsive-controls
- air-detection-failure
- software-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- REF List Number: 21-2101-0200-02
- UDI/DI 30610586035337
- Serial Numbers: 1006964
- 1006966
- 1006969
- 1008404
- 1008405
- 1009451
- 1010631
- 1014398
- 1010689
- 1010420
- 1010442
- 1010443
- 1010444
- 1010445
- 1005368
- 1005365
- 1006283
- 1006298
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03
- SevereAbiomed Automated Impella Controller recalled for motor control and pump failure risks
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03